Jun 18, 2026 06:59AM
Jun 2, 2026 08:02AM
Jun 2, 2026 08:00AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:56AM
Jun 1, 2026 06:55AM Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
May 29, 2026 08:02AM
May 29, 2026 08:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM
May 20, 2026 06:59AM
May 20, 2026 06:59AM
May 8, 2026 07:00AM Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
May 8, 2026 06:59AM
Apr 30, 2026 07:21AM
Apr 30, 2026 07:03AM
Apr 30, 2026 06:59AM
Apr 24, 2026 06:59AM
Apr 24, 2026 06:59AM
Apr 15, 2026 10:36AM Raymond James Preview Bristol-Myers Squibb Co. (BMY) Earnings: 'Our updated diluted non-GAAP EPS is $1.49 for 1Q26 '
Apr 8, 2026 07:33AM
Mar 30, 2026 04:21AM
Mar 29, 2026 11:45AM
Mar 29, 2026 11:45AM
Mar 28, 2026 07:00AM
Mar 23, 2026 06:59AM
Mar 20, 2026 04:42PM Bristol Myers Squibb wins FDA and EU approvals for Opdivo in Hodgkin lymphoma
Mar 20, 2026 04:42PM
Mar 19, 2026 06:59AM
Mar 9, 2026 06:59AM
Mar 9, 2026 06:59AM
Mar 6, 2026 09:59PM
Mar 6, 2026 09:59PM
Feb 26, 2026 06:59AM Iza-bren meets dual endpoints in phase III breast cancer trial
Feb 26, 2026 06:59AM
Feb 23, 2026 08:29AM
Feb 23, 2026 06:59AM
Feb 23, 2026 06:59AM
Feb 20, 2026 07:58AM
Feb 17, 2026 07:00AM
Feb 17, 2026 06:59AM U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
Feb 10, 2026 07:44AM
Feb 5, 2026 07:30AM
Feb 5, 2026 07:00AM
Feb 5, 2026 06:59AM
Jan 12, 2026 06:59AM
Jan 12, 2026 06:59AM
Jan 9, 2026 07:33AM Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Scotiabank
Dec 19, 2025 03:05PM

1,200,292 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All